3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
23
Fallopian Tube Neoplasms
20
Breast Neoplasms
9
Carcinoma, Ovarian Epithelial
8
Sarcoma
6
Neoplasms
4
Neoplasm Metastasis
4
Triple Negative Breast Neoplasms
3
Sarcoma, Kaposi
2
Sarcoma, Ewing
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Multi-centric Castleman's Disease
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell
2
Leiomyosarcoma
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Acquired Immunodeficiency Syndrome
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Cancer Recurrent
1
Interventions
Cisplatin
15
Pemetrexed
12
pembrolizumab
9
Carboplatin
8
Nivolumab
7
Platinum
6
Cyclophosphamide
6
Ipilimumab
5
1,2-diaminocyclohexaneplatinum II citrate
5
fludarabine
3
atezolizumab
3
Radiotherapy, Intensity-Modulated
3
Interleukin-2
3
Gemcitabine
3
tremelimumab
2
durvalumab
2
aldesleukin
2
Radiotherapy
2
Radiation
2
Photochemotherapy
2
Pharmaceutical Preparations
2
Methotrexate
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
Cerebral Decortication
2
nintedanib
1
methoxyamine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
cediranib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
liposomal doxorubicin
×
1 year
×
Clear all
No trials found.